Sarah Mirza

Results-driven Senior Clinical Research Coordinator with 4 years of experience in exceptional leadership capabilities and stellar record of delivering high-impact clinical trials. Adept at orchestrating complex research operations, ensuring strict adherence to regulatory standards, including GCP and US FDA protocols. Proven ability to surpass recruitment targets, streamline data processes, and drive research excellence with meticulous attention to detail. Recognized for exemplary team management, strategic problem-solving, and fostering strong sponsor and investigator relationships. Successfully led multi-site, global clinical trials with zero audit findings, enhancing organizational credibility. Passionate about contributing to innovative medical advancements and improving patient outcomes through evidence-based research. Known for impeccable data integrity, superior communication skills, and unwavering commitment to ethical practices. Highly commended for leading cross-functional teams, mentoring junior staff, and developing novel treatment protocols that significantly enhanced trial efficacy. 

• Spearheaded the coordination and execution of two national and ten international clinical trials, ensuring seamless operations across all study phases.
• Facilitated a 30% increase in participant recruitment beyond the target within the designated timeline by implementing strategic outreach initiatives.
• Streamlined data collection and validation workflows, leading to a 20% improvement in data accuracy and a significant reduction in discrepancies.
• Contributed to the development of an innovative treatment protocol, resulting in a 15% enhancement in patient response rates.

• Spearheaded the coordination and execution of two national and ten international clinical trials, ensuring seamless operations across all study phases.
• Facilitated a 30% increase in participant recruitment beyond the target within the designated timeline by implementing strategic outreach initiatives.
• Streamlined data collection and validation workflows, leading to a 20% improvement in data accuracy and a significant reduction in discrepancies.
• Contributed to the development of an innovative treatment protocol, resulting in a 15% enhancement in patient response rates.